Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ANIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1991. Start Trial.
Date Value
October 31, 2025 15.17M
October 31, 2024 19.92M
October 31, 2023 23.84M
October 31, 2022 29.69M
October 31, 2021 35.73M
October 31, 2020 9.057M
October 31, 2019 5.842M
October 31, 2018 5.056M
October 31, 2017 6.839M
October 31, 2016 3.238M
October 31, 2015 6.769M
October 31, 2014 5.861M
October 31, 2013 0.8982M
October 31, 2012 0.8397M
October 31, 2011 3.023M
October 31, 2010 1.094M
October 31, 2009 2.201M
October 31, 2008 1.921M
Date Value
October 31, 2007 1.069M
October 31, 2006 1.320M
October 31, 2005 0.9073M
October 31, 2004 1.003M
October 31, 2003 1.023M
October 31, 2002 0.855M
October 31, 2001 1.317M
October 31, 2000 1.231M
October 31, 1999 2.076M
October 31, 1998 5.406M
October 31, 1997 13.33M
October 31, 1996 22.17M
October 31, 1995 8.864M
October 31, 1994 6.245M
October 31, 1993 8.317M
October 31, 1992 4.118M
October 31, 1991 4.149M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. 919.37M
Oncolytics Biotech, Inc. 5.202M
Sangamo Therapeutics, Inc. 20.95M
Sarepta Therapeutics, Inc. 939.65M
Vicapsys Life Sciences, Inc. 0.0026M